Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02817633
Brief Title: A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)

First Submitted : June 22, 2016
First Submitted that Met QC Criteria : June 24, 2016
First Posted : June 29, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 13, 2019
Last Update Posted : September 16, 2019